D-0852-2021 Class III Terminated

Recalled by New Vision Pharmaceuticals LLC — Tamarac, FL

FDA drug recall D-0852-2021 was initiated by New Vision Pharmaceuticals LLC on Sep 2, 2021 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jun 21, 2023). Affected quantity: 14,976 FG cartons.

Recall Details

Product Type
Drugs
Report Date
Oct 6, 2021
Initiation Date
Sep 2, 2021
Termination Date
Jun 21, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,976 FG cartons

Product Description

Daytime Severe Cold & Flu Relief 8 Pre-Measured Vials 0.51 FL OZ (15 mL) Each 4.06 FL OZ (120 mL) Total/Nighttime Severe Cold & Flu Relief 8 Pre-Measured Vials 1.01 FL OZ (30 mL) Each 8.12 FL OZ (240 mL) Total Single-Use Vials Mixed Berry Flavor NDC 69842-495-16 UPC 0 50428 64057 9 Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895

Reason for Recall

Subpotent Drug

Distribution Pattern

AL, CA, FL, IN, MI, MO, NJ, NY, PA, RI, SC, TN, TX, VA

Code Information

Lot: 2021-10159 Exp. 06/08/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0852-2021
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0852-2021. Report a data issue: hello@regdatalab.com.